NCT02577614View on ClinicalTrials.gov

FEIBA and Use of Blood Products in Cardiac Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

March 31, 2020

Conditions
Cardiovascular Disease
Interventions
DRUG

FEIBA

Administration of FEIBA after cardiopulmonary bypass

DRUG

Normal Saline

Administration of placebo after cardiopulmonary bypass

Trial Locations (1)

97239

Oregon Health and Science University, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT02577614 - FEIBA and Use of Blood Products in Cardiac Surgery | Biotech Hunter | Biotech Hunter